Physician profile
David Sean Greschler
NPI 1740556679
$1,510.30
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $350 · 2021: $264 · 2022: $284 · 2023: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $260.90 | 2019-2022 | |
| Abbott Laboratories | $173.63 | 2019-2021 | |
| Nevro Corp. | $137.03 | 2019-2023 | Senza |
| Medtronic USA, INC. | $129.71 | 2019 | |
| Pfizer INC. | $121.34 | 2019-2021 | |
| Vgi Medical, LLC | $104.90 | 2022 | |
| Si-Bone, INC. | $81.72 | 2022-2023 | |
| Boston Scientific Corporation | $70.01 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $65.43 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $46.93 | 2020-2021 | |
| Amgen INC. | $41.69 | 2019-2020 | |
| Alphatec Spine, INC | $35.71 | 2021 | |
| Medtronic, INC. | $34.70 | 2022-2023 | Intellis Adaptivestim |
| Almatica Pharma LLC | $30.91 | 2022 | |
| Stimwave Technologies Incorporated | $29.29 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $28.62 | 2020-2021 | |
| Grt US Holding, INC. | $27.35 | 2021 | |
| Allergan, INC. | $26.70 | 2020 | |
| Pacira Therapeutics, INC. | $25.92 | 2021 | |
| Abbvie INC. | $14.31 | 2022 | |
| Hikma Pharmaceuticals USA | $13.37 | 2022 | |
| Fidia Pharma USA INC. | $10.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Greschler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.